Extracellular Vesicles: Bridging the Heart and Tumor in Reverse Cardio-Oncology

HomeCirculationVol. 149, No. 22Extracellular Vesicles: Bridging the Heart and Tumor in Reverse Cardio-Oncology No AccessEditorialRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessFull TextExtracellular Vesicles: Bridging the Heart and Tumor in Reverse Cardio-Oncology Alexandra A.C. Newman, Richard Von Itter and Kathryn J. Moore Alexandra A.C. NewmanAlexandra A.C. Newman https://orcid.org/0000-0001-8938-2428 Cardiovascular Research Center, Leon H. Charney Division of Cardiology, Department of Medicine, New York University Langone Health (A.A.C.N., R.V.I., K.J.M.). , Richard Von ItterRichard Von Itter https://orcid.org/0000-0001-8081-8328 Cardiovascular Research Center, Leon H. Charney Division of Cardiology, Department of Medicine, New York University Langone Health (A.A.C.N., R.V.I., K.J.M.). and Kathryn J. MooreKathryn J. Moore Correspondence to: Kathryn J. Moore, PhD, New York University Langone Health, 435 E 30th St, Science Building 706, New York, NY 10016. Email E-mail Address: [email protected] https://orcid.org/0000-0003-2505-2547 Cardiovascular Research Center, Leon H. Charney Division of Cardiology, Department of Medicine, New York University Langone Health (A.A.C.N., R.V.I., K.J.M.). Department of Cell Biology, New York University Grossman School of Medicine (K.J.M.). Originally published28 May 2024https://doi.org/10.1161/CIRCULATIONAHA.124.069379Circulation. 2024;149:1749–1751This article is a commentary on the followingSmall Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor GrowthFootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Disclosures, see page 1751.Circulation is available at www.ahajournals.org/journal/circCorrespondence to: Kathryn J. Moore, PhD, New York University Langone Health, 435 E 30th St, Science Building 706, New York, NY 10016. Email kathryn.moore@nyulangone.orgREFERENCES1. Herrlich A, Kefaloyianni E, Rose-John S. Mechanisms of interorgan crosstalk in health and disease.FEBS Lett. 2022; 596:529–533. doi: 10.1002/1873-3468.14313CrossrefMedlineGoogle Scholar2. Caller T, Rotem I, Shaihov–Teper O, Lendengolts D, Schary Y, Shai R, Glick-Saar E, Dominissini D, Motiei M, Katzir I, et al. Small extracellular vesicles from infarcted and failing heart accelerate tumor growth.Circulation. 2024; 149:1729–1748. doi: 10.1161/CIRCULATIONAHA.123.066911LinkGoogle Scholar3. Bell CF, Lei X, Haas A, Baylis RA, Gao H, Luo L, Giordano SH, Wehner MR, Nead KT, Leeper NJ. Risk of cancer after diagnosis of cardiovascular disease.JACC CardioOncol. 2023; 5:431–440. doi: 10.1016/j.jaccao.2023.01.010CrossrefMedlineGoogle Scholar4. Koelwyn GJ, Newman AAC, Afonso MS, van Solingen C, Corr EM, Brown EJ, Albers KB, Yamaguchi N, Narke D, Schlegel M, et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming.Nat Med. 2020; 26:1452–1458. doi: 10.1038/s41591-020-0964-7CrossrefMedlineGoogle Scholar5. Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, Haubner BJ, Nagengast WB, Lyon AR, van der Vegt B, et al. Heart failure stimulates tumor growth by circulating factors.Circulation. 2018; 138:678–691. doi: 10.1161/CIRCULATIONAHA.117.030816LinkGoogle Scholar6. Koelwyn GJ, Aboumsallem JP, Moore KJ, de Boer RA. Reverse cardio-oncology: exploring the effects of cardiovascular disease on cancer pathogenesis.J Mol Cell Cardiol. 2022; 163:1–8. doi: 10.1016/j.yjmcc.2021.09.008CrossrefMedlineGoogle Scholar7. de Wit S, Geerlings L, Shi C, Dronkers J, Schouten EM, Blancke G, Andries V, Yntema T, Meijers WC, Koonen DPY, et al. Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.Cardiovasc Res. 2024; doi: 10.1093/cvr/cvae038CrossrefMedlineGoogle Scholar8. Avraham S, Abu-Sharki S, Shofti R, Haas T, Korin B, Kalfon R, Friedman T, Shiran A, Saliba W, Shaked Y, et al. Early cardiac remodeling promotes tumor growth and metastasis.Circulation. 2020; 142:670–683. doi: 10.1161/CIRCULATIONAHA.120.046471LinkGoogle Scholar9. Tani T, Oikawa M, Misaka T, Ishida T, Takeishi Y. Heart failure post-myocardial infarction promotes mammary tumor growth through the NGF-TRKA pathway.JACC CardioOncol. 2024; 6:55–66. doi: 10.1016/j.jaccao.2023.10.002CrossrefMedlineGoogle Scholar10. Jansen F, Nickenig G, Werner N. Extracellular vesicles in cardiovascular disease.Circ Res. 2017; 120:1649–1657. doi: 10.1161/CIRCRESAHA.117.310752LinkGoogle Scholar11. Potz BA, Scrimgeour LA, Pavlov VI, Sodha NR, Abid MR, Sellke FW. Extracellular vesicle injection improves myocardial function and increases angiogenesis in a swine model of chronic ischemia.J Am Heart Assoc. 2018; 7:e008344. doi: 10.1161/JAHA.117.008344LinkGoogle Scholar12. Yuan Y, Mei Z, Qu Z, Li G, Yu S, Liu Y, Liu K, Shen Z, Pu J, Wang Y, et al. Exosomes secreted from cardiomyocytes suppress the sensitivity of tumor ferroptosis in ischemic heart failure.Signal Transduct Target Ther. 2023; 8:121. doi: 10.1038/s41392-023-01336-4CrossrefMedlineGoogle Scholar13. Shi C, Aboumsallem JP, de Wit S, Schouten EM, Bracun V, Meijers WC, Silljé HHW, de Boer RA. Evaluation of renal cancer progression in a mouse model of heart failure.Cancer Commun (Lond). 2021; 41:796–799. doi: 10.1002/cac2.12185CrossrefMedlineGoogle Scholar14. Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, et al. Tumour exosome integrins determine organotropic metastasis.Nature. 2015; 527:329–335. doi: 10.1038/nature15756CrossrefMedlineGoogle Scholar15. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.Nat Med. 2012; 18:883–891. doi: 10.1038/nm.2753CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesSmall Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor GrowthTal Caller, et al. Circulation. 2024;149:1729-1748 May 28, 2024Vol 149, Issue 22 Advertisement Article InformationMetrics © 2024 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.124.069379PMID: 38805582 Originally publishedMay 28, 2024 KeywordsEditorialscancercardio-oncologycardiovascular diseasecytokinesextracellular vesiclesPDF download Advertisement SubjectsCardio-OncologyHeart FailureMyocardial Infarction